Andere Sprachen Clearbridge Health Limited

Aktien

A2P5MF

SG1EB6000000

1H3

Markt geschlossen - Singapore S.E. Andere Börsenplätze 09:29:40 26.04.2024			% 5 Tage	% 1. Jan.
0,01 ^SGD	0,00 %		0,00 %	-37,50 %

29.02.	Clearbridge Health Limited meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr	CI
21.02.	Singapur-Aktien fallen zum Börsenschluss; ValueMax-Aktien steigen um 11%, da der Gewinn in H2 2023 um 44% steigt	MT

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Clearbridge Health Limited Reports Earnings Results for the Full Year Ended December 31, 2023	29.02.
Singapore Shares Fall at Market Close; ValueMax Shares Climb 11% as H2 2023 Profit Surges 44%	21.02.
Clearbridge Health Cuts Stake in Singapore Institute of Advanced Medicine; Shares Rise 8%	21.02.
Clearbridge Health's Operations Chief to Step Down by Month-End	15.02.
Clearbridge Health Limited Announces Resignation of Liau Yen San, Jonathan as Chief Operating Officer	14.02.
Clearbridge Health Warns of Lower 2023 Revenue from COVID-19 Test Kits, Medical Services	12.02.
Clearbridge Health Receives Full Amount of Outstanding Debt from Biolidics	01.12.
Clearbridge Health Limited Announces Second Partial Settlement Deed	30.11.
Singapore Stocks End Week in Red; Noel Gifts Zooms 38% as Collective Sale of 50 Playfair Road Singapore Closes	24.11.
Clearbridge Health Unit, Biolidics Sign Deal for Partial Debt Settlement	24.11.
Clearbridge Health Limited Reports Earnings Results for the Half Year Ended June 30, 2023	14.08.23
Clearbridge Health to Dispose of Over 10% Stake in Biolidics	24.07.23
Clearbridge Health Limited Announces Board Changes	28.06.23
Clearbridge Health Issues Shares Under Performance Share Plan	17.05.23
Clearbridge Health Limited Announces Retirement of Tan Soon Liang (Chen Shunliang) as Independent Director	12.05.23
Clearbridge Health Trims Losses in July-December 2022	08.05.23
Clearbridge Health Limited Reports Earnings Results for the Full Year Ended December 31, 2022	07.05.23
Clearbridge Health Gets More Time from ACRA to Hold AGM, File Annual Returns	07.04.23
Biolidics Issues 37.5 Million Shares as Partial Consideration for Biomedics Acquisition	21.03.23
Biolidics Gets Regulatory Nod to List Consideration Shares for Biomedics Acquisition; Shares Surge 7%	17.03.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Clearbridge Health Limited

Aktien

A2P5MF

SG1EB6000000

1H3

Andere Sprachen

Filter